Redeye initiates coverage of Medicover

We initiate coverage on Medicover. Medicover has over twenty years of history of providing healthcare and diagnostic services to patients in Central and Eastern Europe (CEE) and has built a leading position in several of these fast-growing private healthcare markets. Despite a strong performance for the share in 2019, we believe the Medicover growth story still is underestimated by the market, and that the stock is currently trading at a discount to its peers.

Read more and download the research update: http://bit.ly/339rBTV

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/